Urologix, Inc. (ULGX)

Market Cap	21.00
Revenue (ttm)	12.00M -19.4%
Net Income	-4.67M
EPS	-0.22
Shares Out	21.28M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,001
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0126
Beta	-114.31
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Urologix

Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethr...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1991
• Employees: 61
• Stock Exchange: OTCMKTS
• Ticker Symbol: ULGX

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 16, 2026

Data Sources Report a data error